Home/ Stocks/ TPST

Tempest Therapeutics, Inc. Common Stock

TPST XNAS

$1.75 -0.07 (-3.84%) ▼ 15-min delayed

Open

$1.83

High

$1.85

Low

$1.75

Volume

99.2K

Market Cap

$24.81M

About Tempest Therapeutics, Inc. Common Stock

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 5 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	N/A	$-3,511,000	$-0.79
Q2 2025	N/A	$-7,870,000	$-2.07
Q1 2025	N/A	$-10,860,000	$-3.16
FY 2024	N/A	$-41,843,000	$-1.50

Related Market News

No specific coverage for TPST yet. Check out our latest market news or earnings calendar.

Get TPST Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Tempest Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.